209 related articles for article (PubMed ID: 22100451)
41. The activity and expression of NTPDase is altered in lymphocytes of multiple sclerosis patients.
Spanevello RM; Mazzanti CM; Schmatz R; Thomé G; Bagatini M; Correa M; Rosa C; Stefanello N; Bellé LP; Moretto MB; Oliveira L; Morsch VM; Schetinger MR
Clin Chim Acta; 2010 Feb; 411(3-4):210-4. PubMed ID: 19914228
[TBL] [Abstract][Full Text] [Related]
42. Ecto-hydrolysis of adenine nucleotides in rat blood platelets are altered by ovariectomy.
Pochmann D; Böhmer AE; Nejar Bruno A; Sarkis JJ
Platelets; 2005 Sep; 16(6):334-9. PubMed ID: 16194863
[TBL] [Abstract][Full Text] [Related]
43. Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions.
Yegutkin GG; Henttinen T; Jalkanen S
FASEB J; 2001 Jan; 15(1):251-260. PubMed ID: 11149913
[TBL] [Abstract][Full Text] [Related]
44. Soluble apyrases release adp during ATP hydrolysis.
Chen W; Guidotti G
Biochem Biophys Res Commun; 2001 Mar; 282(1):90-5. PubMed ID: 11263976
[TBL] [Abstract][Full Text] [Related]
45. Reconstitution of CD39 in liposomes amplifies nucleoside triphosphate diphosphohydrolase activity and restores thromboregulatory properties.
Haller CA; Cui W; Wen J; Robson SC; Chaikof EL
J Vasc Surg; 2006 Apr; 43(4):816-23. PubMed ID: 16616242
[TBL] [Abstract][Full Text] [Related]
46. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis.
Glenn JR; White AE; Johnson AJ; Fox SC; Myers B; Heptinstall S
Platelets; 2008 Feb; 19(1):59-69. PubMed ID: 18231939
[TBL] [Abstract][Full Text] [Related]
47. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.
Imai M; Takigami K; Guckelberger O; Enjyoji K; Smith RN; Lin Y; Csizmadia E; Sévigny J; Rosenberg RD; Bach FH; Robson SC
Mol Med; 1999 Nov; 5(11):743-52. PubMed ID: 10656876
[TBL] [Abstract][Full Text] [Related]
48. The effects of angiotensin II and genetic hypertension upon extracellular nucleotide hydrolysis by rat platelet ectoenzymes.
Fürstenau CR; Trentin DS; Barreto-Chaves ML; Sarkis JJ
Thromb Res; 2007; 120(6):877-84. PubMed ID: 17343900
[TBL] [Abstract][Full Text] [Related]
49. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R
Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226
[TBL] [Abstract][Full Text] [Related]
50. Crystal structure of E. coli Hsp100 ClpB nucleotide-binding domain 1 (NBD1) and mechanistic studies on ClpB ATPase activity.
Li J; Sha B
J Mol Biol; 2002 May; 318(4):1127-37. PubMed ID: 12054807
[TBL] [Abstract][Full Text] [Related]
51. E-NTPDase and E-ADA activities are altered in lymphocytes of patients with indeterminate form of Chagas' disease.
Souza Vdo C; Schlemmer KB; Noal CB; Jaques JA; Zimmermann CE; Leal CA; Fleck J; Casali EA; Morsch VM; Schetinger MR; Leal DB
Parasitol Int; 2012 Dec; 61(4):690-6. PubMed ID: 22846899
[TBL] [Abstract][Full Text] [Related]
52. Effect of high glucose levels in human platelet NTPDase and 5'-nucleotidase activities.
Lunkes GI; Lunkes DS; Leal D; Araújo Mdo C; Corrêa M; Becker L; Rosa CS; Morsch VM; Schetinger MR
Diabetes Res Clin Pract; 2008 Sep; 81(3):351-7. PubMed ID: 18644642
[TBL] [Abstract][Full Text] [Related]
53. Activities of enzymes that hydrolyze adenine nucleotides in lymphocytes from patients with rheumatoid arthritis.
Dos Santos Jaques JA; Becker LV; Souza Vdo C; Leal CA; Bertoldo TM; de Vargas Pinheiro K; Morsch VM; Schetinger MR; Leal DB
Cell Biochem Funct; 2013 Jul; 31(5):395-9. PubMed ID: 23070807
[TBL] [Abstract][Full Text] [Related]
54. Characterization of an ectonucleoside triphosphate diphosphohydrolase 1 activity in alkaline phosphatase-depleted rat osseous plate membranes: possible functional involvement in the calcification process.
Demenis MA; Furriel RP; Leone FA
Biochim Biophys Acta; 2003 Mar; 1646(1-2):216-25. PubMed ID: 12637029
[TBL] [Abstract][Full Text] [Related]
55. Regulation of P2Y1 receptor-mediated signaling by the ectonucleoside triphosphate diphosphohydrolase isozymes NTPDase1 and NTPDase2.
Alvarado-Castillo C; Harden TK; Boyer JL
Mol Pharmacol; 2005 Jan; 67(1):114-22. PubMed ID: 15496502
[TBL] [Abstract][Full Text] [Related]
56. 24-hour temporal pattern of NTPDase and 5'-nucleotidase enzymes in rat blood serum.
Detanico BC; de Souza A; Medeiros LF; Rozisky JR; Caumo W; Hidalgo MP; Battastini AM; Torres IL
Chronobiol Int; 2010 Oct; 27(9-10):1751-61. PubMed ID: 20969521
[TBL] [Abstract][Full Text] [Related]
57. Schiff bases of tryptamine as potent inhibitors of nucleoside triphosphate diphosphohydrolases (NTPDases): Structure-activity relationship.
Kanwal ; Mohammed Khan K; Salar U; Afzal S; Wadood A; Taha M; Perveen S; Khan H; Lecka J; Sévigny J; Iqbal J
Bioorg Chem; 2019 Feb; 82():253-266. PubMed ID: 30391856
[TBL] [Abstract][Full Text] [Related]
58. Dynamic motions of CD39 transmembrane domains regulate and are regulated by the enzymatic active site.
Grinthal A; Guidotti G
Biochemistry; 2004 Nov; 43(43):13849-58. PubMed ID: 15504047
[TBL] [Abstract][Full Text] [Related]
59. ATP and ADP hydrolysis in the kidney and liver of fish, chickens and rats.
Vieira VL; Morsch VM; Lermen CL; da Silva AC; Tabaldi LA; Schetinger MR
Comp Biochem Physiol B Biochem Mol Biol; 2004 Dec; 139(4):713-20. PubMed ID: 15581803
[TBL] [Abstract][Full Text] [Related]
60. Identifiability of enzyme kinetic parameters in substrate competition: a case study of CD39/NTPDase1.
McGuinness AN; Tahir A; Sutton NR; Marquis AD
Purinergic Signal; 2024 Jun; 20(3):257-271. PubMed ID: 37165287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
